Evidence used
- No CISA KEV confirmation is currently recorded.
- The selected CVSS metric records a network-reachable, unauthenticated path with no user interaction.
- EPSS is 9.71% for the current model date.
BlackTreeCVE IntelligenceUnknown · Unknown
Critical technical impact with a remotely reachable, unauthenticated path; no CISA KEV confirmation is currently recorded.
Debian findings are scoped to the named distribution, release and source package. An absent finding does not mean a package is unaffected.
A published vendor fix does not prove that a matching update is enabled and installable on a particular asset. Confirm the local package candidate before scheduling remediation.
| Distribution release | Source package | Vendor state | Fixed version | Evidence |
|---|---|---|---|---|
| Debian trixietrixie · source | activemq | Vendor fix publishedDebian records a fixed source-package version for this release. | 5.6.0+dfsg1-4 | Debian Security Tracker ↗Source updated 5 Oct 2026 |
| Debian bookwormbookworm · source | activemq | Vendor fix publishedDebian records a fixed source-package version for this release. | 5.6.0+dfsg1-4 | Debian Security Tracker ↗Source updated 5 Oct 2026 |
| Debian sidsid · source | activemq | Vendor fix publishedDebian records a fixed source-package version for this release. | 5.6.0+dfsg1-4 | Debian Security Tracker ↗Source updated 5 Oct 2026 |
Critical technical impact with a remotely reachable, unauthenticated path; no CISA KEV confirmation is currently recorded.
Fix not verifiedXML external entity (XXE) vulnerability in Apache ActiveMQ 5.x before 5.10.1 allows remote consumers to have unspecified impact via vectors involving an XPath based selector when dequeuing XML messages.
XML external entity (XXE) vulnerability in Apache ActiveMQ 5.x before 5.10.1 allows remote consumers to have unspecified impact via vectors involving an XPath based selector when dequeuing XML messages.
The product processes an XML document that can contain XML entities with URIs that resolve to documents outside of the intended sphere of control, causing the product to embed incorrect documents into its output.
An attacker operating through a network path may attempt exploitation without authentication or user interaction. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
XML external entity (XXE) vulnerability in Apache ActiveMQ 5.x before 5.10.1 allows remote consumers to have unspecified impact via vectors involving an XPath based selector when dequeuing XML messages.
The product processes an XML document that can contain XML entities with URIs that resolve to documents outside of the intended sphere of control, causing the product to embed incorrect documents into its output.
An attacker operating through a network path may attempt exploitation without authentication or user interaction. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.
CWE-611: Improper Restriction of XML External Entity Reference. The product processes an XML document that can contain XML entities with URIs that resolve to documents outside of the intended sphere of control, causing the product to embed incorrect documents into its output.
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:HCommon Vulnerability Scoring System 3.0: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 27 Oct 2017 · Last source change 6 Aug 2024, 10:50 UTC · CWE-611 · Improper Restriction of XML External Entity Reference
Missing structured fields: affected product. Missing data is not evidence of low risk; review the primary advisory.